<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: clinical tests</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Standard criteria needed for spinal stenosis diagnosis</title>
   	 <description>(HealthDay)—There is a need for a consensus on criteria to define and classify lumbar spinal stenosis, according to a review published in the April 15 issue of Spine.</description>
     <link>http://medicalxpress.com/news/2013-04-standard-criteria-spinal-stenosis-diagnosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 28 Apr 2013 06:30:01 EST</pubDate>
	 <guid isPermaLink="false">news286347699</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-standardcrit.jpg" width="90" height="90" />
</item>
<item>
     <title>Differential hearing difficulties cause kids to fall behind at school</title>
   	 <description>(Medical Xpress)—Some children who have trouble learning in the classroom have difficulty switching their listening attention and so have trouble following a conversation from one talker to the next, according to a University of Sydney study published online in Nature's Scientific Reports.</description>
     <link>http://medicalxpress.com/news/2013-04-differential-difficulties-kids-fall-school.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Fri, 05 Apr 2013 06:37:37 EST</pubDate>
	 <guid isPermaLink="false">news284362645</guid>
	 
</item>
<item>
     <title>Himalaya, India's booming herbal healthcare company</title>
   	 <description>Its raw materials are plants and it bases its products on texts dating back millennia, but don't dare call India's biggest herbal healthcare group a maker of &quot;alternative medicine&quot;.</description>
     <link>http://medicalxpress.com/news/2013-03-himalaya-india-booming-herbal-healthcare.html</link>
	 <category>Medications</category>
	 <pubDate>Sun, 31 Mar 2013 09:40:04 EST</pubDate>
	 <guid isPermaLink="false">news283940093</guid>
	 
</item>
<item>
     <title>Is it a stroke or benign dizziness? A simple bedside test can tell</title>
   	 <description>A bedside electronic device that measures eye movements can successfully determine whether the cause of severe, continuous, disabling dizziness is a stroke or something benign, according to results of a small study led by Johns Hopkins Medicine researchers.</description>
     <link>http://medicalxpress.com/news/2013-03-benign-dizziness-simple-bedside.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 05 Mar 2013 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news281710123</guid>
	 
</item>
<item>
     <title>Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens</title>
   	 <description>A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants.</description>
     <link>http://medicalxpress.com/news/2013-03-early-antiretroviral-treatment-viral-reservoirs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 04 Mar 2013 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news281624209</guid>
	 
</item>
<item>
     <title>Lupus: Peptide P140/LupuzorTM effectiveness confirmed</title>
   	 <description>A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.</description>
     <link>http://medicalxpress.com/news/2013-01-lupus-peptide-p140lupuzortm-effectiveness.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Fri, 25 Jan 2013 06:36:19 EST</pubDate>
	 <guid isPermaLink="false">news278318172</guid>
	 
</item>
<item>
     <title>Discovering a new role for a breast cancer gene</title>
   	 <description>(Medical Xpress)—Researchers at the School of Biosciences have identified an unexpected role for a tumour-associated gene in breast cancer.</description>
     <link>http://medicalxpress.com/news/2013-01-role-breast-cancer-gene.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 18 Jan 2013 07:45:30 EST</pubDate>
	 <guid isPermaLink="false">news277717518</guid>
	 
</item>
<item>
     <title>New hope for setback-dogged cancer treatment</title>
   	 <description>Several drugs companies have ineffectively tried to produce antibodies that bind to the IGF-1 receptor on the cell surface, which has a critical part to play in the development of cancer. Scientists at Karolinska Institutet in Sweden have now ascertained how these antibodies work, and can explain why only some cancer patients are helped by IGF-1 blockers during clinical tests. The researchers also present a means by which drugs of this kind could help more cancer patients.</description>
     <link>http://medicalxpress.com/news/2012-11-setback-dogged-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Nov 2012 15:54:16 EST</pubDate>
	 <guid isPermaLink="false">news273167641</guid>
	 
</item>
<item>
     <title>Offering a reward can improve visual awareness in stroke patients</title>
   	 <description>Stroke patients who have difficulty paying attention to part of their visual field may perform better when offered a reward, a study by Imperial College London and Brunel University researchers has found.</description>
     <link>http://medicalxpress.com/news/2012-11-reward-visual-awareness-patients.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 26 Nov 2012 13:29:32 EST</pubDate>
	 <guid isPermaLink="false">news273158939</guid>
	 
</item>
<item>
     <title>Older adults worse at distinguishing between lifted weights than younger counterparts</title>
   	 <description>As we grow older, we are less capable of correctly estimating differences in the weights of objects we lift, according to a study published Oct. 24 in the open access journal PLOS ONE by Jessica Holmin and Farley Norman from North Dakota State University and Western Kentucky University, respectively.</description>
     <link>http://medicalxpress.com/news/2012-10-older-adults-worse-distinguishing-weights.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 24 Oct 2012 18:20:01 EST</pubDate>
	 <guid isPermaLink="false">news270318655</guid>
	 
</item>
<item>
     <title>Quick, cheap retina scan can predict brain damage caused by multiple sclerosis</title>
   	 <description>An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two Johns Hopkins studies.</description>
     <link>http://medicalxpress.com/news/2012-10-quick-cheap-retina-scan-brain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 17 Oct 2012 03:14:10 EST</pubDate>
	 <guid isPermaLink="false">news269662441</guid>
	 
</item>
<item>
     <title>10 drugmakers team up to improve testing process</title>
   	 <description>(AP)—Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.</description>
     <link>http://medicalxpress.com/news/2012-09-drugmakers-team.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 19 Sep 2012 13:27:45 EST</pubDate>
	 <guid isPermaLink="false">news267280061</guid>
	 
</item>
<item>
     <title>New study discovers genomic variant that increases risk of some brain tumors</title>
   	 <description>People who carry a &quot;G&quot; instead of an &quot;A&quot; at a specific spot in the sequence of their genetic code have roughly a six-fold higher risk of developing certain types of brain tumors, according to a study by researchers at the University of California, San Francisco and Mayo Clinic.</description>
     <link>http://medicalxpress.com/news/2012-08-genomic-variant-brain-tumors.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 26 Aug 2012 13:00:23 EST</pubDate>
	 <guid isPermaLink="false">news265182826</guid>
	 
</item>
<item>
     <title>Attitude towards age increases risk of dementia diagnosis</title>
   	 <description>Our attitude towards our age has a massive impact on the likelihood of being diagnosed with dementia. New research shows that when seniors see themselves as 'older' their performance on a standard dementia screening test declines dramatically; making them five times more likely to meet the criteria for dementia.</description>
     <link>http://medicalxpress.com/news/2012-06-attitude-age-dementia-diagnosis.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 11 Jun 2012 19:00:01 EST</pubDate>
	 <guid isPermaLink="false">news258658624</guid>
	 
</item>
<item>
     <title>One-fifth of healthy middle-aged men have low-grade murmur</title>
   	 <description>(HealthDay) -- More than one-fifth of healthy middle-aged men have a low-grade systolic heart murmur that confers a nearly five-fold higher risk of future aortic valve replacement (AVR), according to a study published in the June issue of the Journal of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-05-one-fifth-healthy-middle-aged-men-low-grade.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 25 May 2012 13:10:01 EST</pubDate>
	 <guid isPermaLink="false">news257167037</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/onefifthofhe.jpg" width="90" height="90" />
</item>
<item>
     <title>Excessive sleepiness may be cause of learning, attention and school problems</title>
   	 <description>Children who have learning, attention and behavior problems may be suffering from excessive daytime sleepiness, even though clinical tests show them sleeping long enough at night, a new study reports.</description>
     <link>http://medicalxpress.com/news/2012-05-excessive-sleepiness-attention-school-problems.html</link>
	 <category>Sleep apnea</category>
	 <pubDate>Tue, 01 May 2012 03:30:02 EST</pubDate>
	 <guid isPermaLink="false">news255060366</guid>
	 
</item>
<item>
     <title>S.Africa conducts trials for shorter TB treatment</title>
   	 <description> South African researchers said Friday they were conducting medical trials to shorten the duration of tuberculosis treatment to make it easier for patients to complete the full regimen.</description>
     <link>http://medicalxpress.com/news/2012-03-safrica-trials-shorter-tb-treatment.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 30 Mar 2012 09:38:14 EST</pubDate>
	 <guid isPermaLink="false">news252319081</guid>
	 
</item>
<item>
     <title>Trial for new drug-resistant TB treatment to begin</title>
   	 <description> A global health alliance Monday unveiled plans for the first clinical tests of a new treatment regimen for tuberculosis, including for patients with resistance to existing multidrug programs.</description>
     <link>http://medicalxpress.com/news/2012-03-trial-drug-resistant-tb-treatment.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 19 Mar 2012 13:55:05 EST</pubDate>
	 <guid isPermaLink="false">news251384097</guid>
	 
</item>
<item>
     <title>Cuba to test new AIDS vaccine on humans</title>
   	 <description> Cuba's top biotech teams have successfully tested a new AIDS vaccine on mice, and are ready to soon begin human testing, a leading researcher told a biotechnology conference in Havana on Monday.</description>
     <link>http://medicalxpress.com/news/2012-03-cuba-aids-vaccine-humans.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 06 Mar 2012 04:30:01 EST</pubDate>
	 <guid isPermaLink="false">news250229668</guid>
	 
</item>
<item>
     <title>Study identifies a cause of resistance to colon cancer treatment</title>
   	 <description>Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.</description>
     <link>http://medicalxpress.com/news/2012-01-resistance-colon-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 22 Jan 2012 13:04:32 EST</pubDate>
	 <guid isPermaLink="false">news246459858</guid>
	 
</item>
<item>
     <title>Study identifies novel markers as key indicators of future renal failure in diabetes</title>
   	 <description>Scientists at Joslin Diabetes Center have identified two novel markers that, when elevated in the blood stream, can predict accurately the risk of renal (kidney) failure in patients with Type 1 and Type 2 diabetes. The findings have immediate diagnostic implications and can be used for the development of new therapies to prevent or postpone the progression of renal disease in diabetes.</description>
     <link>http://medicalxpress.com/news/2012-01-markers-key-indicators-future-renal.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 19 Jan 2012 17:28:44 EST</pubDate>
	 <guid isPermaLink="false">news246216514</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/joslinstudyi.jpg" width="90" height="90" />
</item>
<item>
     <title>US approves drug for middle-of-the-night insomniacs</title>
   	 <description> The US Food and Drug Administration, for the first time, approved Wednesday medication specifically designed for those who wake up in the middle of the night and cannot fall back to sleep.</description>
     <link>http://medicalxpress.com/news/2011-11-drug-middle-of-the-night-insomniacs.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 23 Nov 2011 16:48:19 EST</pubDate>
	 <guid isPermaLink="false">news241289287</guid>
	 
</item>
<item>
     <title>Several methods for early diagnosis of Alzheimer's disease developed by European scientists</title>
   	 <description>PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.</description>
     <link>http://medicalxpress.com/news/2011-06-methods-early-diagnosis-alzheimer-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 15 Jun 2011 05:10:02 EST</pubDate>
	 <guid isPermaLink="false">news227330809</guid>
	 
</item>
<item>
     <title>New pre-meal dietary supplement can overcome fat and sugar problems</title>
   	 <description>A little bitter with a little sweet, in the form of a nano-complex dietary supplement taken before meals, can result in a substantial reduction of fat and sugar absorption in the body, Hebrew University of Jerusalem and Harvard University researchers have found.</description>
     <link>http://medicalxpress.com/news/2011-05-pre-meal-dietary-supplement-fat-sugar.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 23 May 2011 09:47:30 EST</pubDate>
	 <guid isPermaLink="false">news225362838</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/premealdieta.jpg" width="90" height="90" />
</item>
<item>
     <title>TGen licenses first drug for patient use in clinical care</title>
   	 <description> The Translational Genomics Research Institute (TGen) has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins.</description>
     <link>http://medicalxpress.com/news/2011-05-tgen-drug-patient-clinical.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 04 May 2011 14:48:44 EST</pubDate>
	 <guid isPermaLink="false">news223739298</guid>
	 
</item>


</channel>
</rss>
